The landscape of dementia analysis has advanced drastically with the appearance of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments which can detect Alzheimer's pathology many years ahead of signs and symptoms emerge. Even though these technological innovations signify impressive development in